Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer

Clinical trial NCT05245474 · RECRUITING

Trial details

NCT number: NCT05245474
Sponsor: Beijing Friendship Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Rectal Cancer

Start date: 2022-04-01
Primary completion: 2024-03-01
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.